Pricing Log in Create free account

Celyad SA (CYAD) vs Kyntra Bio Inc (KYNB)

Celyad SA and Kyntra Bio Inc are both Biotechnology companies. Celyad SA and Kyntra Bio Inc are of similar size ($23.8M and $21.7M). Celyad SA has negative trailing earnings, so its P/E is not meaningful; Kyntra Bio Inc trades at 0.1×. Kyntra Bio Inc has the higher net margin (3,967.8% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Kyntra Bio Inc leads on 8 and Celyad SA on 3.

Valuation

Metric CYAD KYNB Biotechnology median
P/E n/m 0.11 8.50
P/S n/m 4.25 9.71
P/B 11.18 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA — n/m 0.64
EV/Sales — 16.35 9.21
Earnings yield (708.87%) 934.02% (33.15%)
Free cash flow yield (438.06%) (194.02%) (25.50%)

Profitability

Metric CYAD KYNB Biotechnology median
Gross margin 0.00% 6.28% 65.16%
Operating margin — (1,089.78%) 0.00%
Net margin 0.00% 3,967.77% 0.00%
Free cash flow margin 0.00% (824.19%) 0.00%
Return on equity 0.00% (157.83%) (56.36%)
Return on assets 0.00% 131.26% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CYAD KYNB Biotechnology median
Revenue growth (TTM) — (37.15%) 6.02%
EPS growth (last fiscal year) 113.33% 478.08% 30.26%
Revenue growth, 5-year CAGR (63.51%) (48.42%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CYAD KYNB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.94 2.69 4.72
Net debt to EBITDA (1.62) 1.97 0.96

Dividend

Metric CYAD KYNB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CYAD KYNB Biotechnology median
Market cap 23.79m 21.70m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack